Delivery Order 75N95022D00013-75N98026F00001
Award Date 9/1/26
Potential Completion Date 8/31/29
Potential Value $159K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Center for Advancing Translational Sciences issued a delivery order to CCS Associates, Inc., a woman-owned small business, on May 21, 2025, with a ceiling value of $545,690.33 under a Total Small Business set-aside for regulatory activities supporting PCCA and MMAB gene therapy products. Place of performance is San Jose, CA. The order exercises Option B and carries an ultimate completion date of May 20, 2028. Work is priced on a labor-hours basis and includes a new statement of work...
- CCS Associates, Inc. was awarded a $419,664 purchase order contract by the Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke to provide regulatory affairs consulting support services. The contract has a period of performance from September 2020 through September 2023. It is designated as a total small business set aside and will be performed by CCS Associates in San Jose, California. The National Institute of...
- This is a one-year, $113,077 cost-plus-fixed-fee delivery order awarded by the National Institutes of Health (NIH)'s National Institute on Drug Abuse to CCS Associates, Inc., a woman-owned small business, for regulatory affairs support. The order is part of a larger indefinite delivery vehicle (IDV) that CCS Associates holds from NIH to provide regulatory affairs assistance through 2028. CCS Associates has extensive experience supporting pharmaceutical research, clinical trials, regulatory...
- The National Institute on Drug Abuse issued a delivery order to CCS Associates, Inc., a woman-owned small business, on June 10, 2022, under the Total Small Business set-aside with a ceiling value of $240,897.48 for preparation of an Investigational New Drug (IND) application with the Food and Drug Administration for a treatment for Jansen's Metaphyseal Chondrodysplasia. Place of performance is San Jose, CA. The order carried an ultimate completion date of June 9, 2025. Work was priced on a...
- The National Institute of Neurological Disorders and Stroke awarded a purchase order to CCS Associates, Inc., a woman-owned small business, for medical writing consulting services, with a ceiling value of $323,278.40 and an award date of September 14, 2023. The order carries a Total Small Business set-aside designation. Work is performed in North Bethesda, Maryland. The contract provides medical writing and regulatory document preparation support for neuroscience drug development programs,...
- This $548,714.60 firm fixed-price delivery order contract was awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. Department of Health and Human Services, to CCS Associates, Inc., a woman-owned small business. The contract is for TAS (Task Area Support) to provide strategic planning and activities support for NCI's Center for Strategic Scientific Initiatives (CSSI). CCS Associates specializes in providing comprehensive research support services to federal agencies,...
- This is a Definitive Contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to CCS Associates, Inc., a woman-owned small business. The contract, valued at $106,370.26, is for regulatory affairs consulting support services related to the Brain Program Network (BPN) initiative. The contract was awarded as a Total Small Business set-aside on September 4, 2015 and is scheduled for completion on September 13, 2020. CCS Associates has...
- This is a definitive contract awarded to CCS Associates, Inc., a woman-owned small business, by the Food and Drug Administration (FDA) for a quality assurance and quality improvement program to review clinical trials supported or funded by the FDA. The contract has a ceiling value of $87,620.95 and a period of performance that ends on March 29, 2019. It is a time and materials contract type. CCS Associates has received numerous federal contracts and grants, including several large indefinite...
- This $1,286,665.09 federal contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to CCS Associates, Inc., a woman-owned small business contract research organization. The contract is a delivery order and has a firm fixed price pricing type. CCS Associates will provide a range of services to support NCI's cancer prevention efforts, including information management, regulatory services, and technical support. The contract is not a set-aside...
- <p>The National Cancer Institute awarded a definitive contract to CCS Associates, Inc., a woman-owned small business, for regulatory support for cancer prevention agent development on September 30, 2011, under a total small business set-aside.</p> <p>The contract carries a ceiling value of $14,612,856.23 on a cost-plus-fixed-fee basis. Place of performance is San Jose, California. The ultimate completion date is September 29, 2018.</p>